Tae Won Kwak

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells

Tae Won Kwak, Su Bum Park, Hyun‐Jung Kim et al. · OncoTargets and Therapy · 2016 · 62 citations · Full text

Medicine, Oncology, Pharmacology +16

Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells

Tae Won Kwak, Do Hyung Kim, Young‐Il Jeong et al. · Journal of Nanobiotechnology · 2015 · 49 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells

Hye Myeong Lee, Young‐Il Jeong, Do Hyung Kim et al. · International Journal of Pharmaceutics · 2013 · 47 citations

Medicine, Oncology, Pharmacology +15

Dextran-b-poly(L-histidine) copolymer nanoparticles for pH-responsive drug delivery to tumor cells

Young‐Il Jeong, Jong-Ho Hwang, Cheol Woong Choi et al. · International Journal of Nanomedicine · 2013 · 41 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells

Do Hyung Kim, Dae Hwan Kang, Young‐Il Jeong et al. · International Journal of Nanomedicine · 2013 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17